By statute: FDA may require the confirmatory study to be underway before accelerated approval; it is NOT an absolute statutory requirement for every accelerated approval. There are exceptions. FDA describes circumstances—e.g., certain rare diseases or a future event needed to conduct the trial—where it may permit the confirmatory trial to start after approval.
Quote:accelerated approval REQUIRES phase 3 UNDERWAY. 100% requirement